FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164018039> ?p ?o ?g. }

• W3164018039 abstract "In 2011 the Food and Drug Administration (FDA) approved anti-vascular endothelial growth factor (VEGF) therapy, bevacizumab, for intractable melanoma. Within the year, immunotherapy modulators inhibiting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) were approved in addition to programmed death-ligand 1 (PD-L1) antibodies in 2012. Since then, research showing the effectiveness of targeted therapies in a wide range of solid tumors has prompted studies incorporating their inclusion as part of upfront management as well as refractory or relapsed disease. For treatment of cervical cancer, which arises from known virus-driven oncogenic pathways, the incorporation of targeted therapy is a particularly attractive prospect. The current standard of care for locally advanced cervical cancer includes concurrent platinum-based chemotherapy with radiation therapy (CRT) including external beam radiation therapy (EBRT) and brachytherapy. Building upon encouraging results from trials testing bevacizumab or immunotherapy in recurrent cervical cancer, these agents have begun to be incorporated into upfront CRT strategies for prospective study. This article will review background data establishing efficacy of angiogenesis inhibitors and immunotherapy in the treatment of cervical cancer as well as results of prospective studies combining targeted therapies with standard CRT with the aim of improving outcomes. In addition, the role of immunotherapy and radiation on the tumor microenvironment (TME) will be discussed." @default.
• W3164018039 created "2021-06-07" @default.
• W3164018039 creator A5009596826 @default.
• W3164018039 creator A5009830957 @default.
• W3164018039 creator A5033385764 @default.
• W3164018039 creator A5077640487 @default.
• W3164018039 date "2021-05-26" @default.
• W3164018039 modified "2023-10-16" @default.
• W3164018039 title "The Incorporation of Immunotherapy and Targeted Therapy Into Chemoradiation for Cervical Cancer: A Focused Review" @default.
• W3164018039 cites W1964256075 @default.
• W3164018039 cites W1985023250 @default.
• W3164018039 cites W2018650910 @default.
• W3164018039 cites W2037364667 @default.
• W3164018039 cites W2047618260 @default.
• W3164018039 cites W2053068747 @default.
• W3164018039 cites W2058904677 @default.
• W3164018039 cites W2062972159 @default.
• W3164018039 cites W2077506515 @default.
• W3164018039 cites W2083773491 @default.
• W3164018039 cites W2090624647 @default.
• W3164018039 cites W2097945491 @default.
• W3164018039 cites W2100756525 @default.
• W3164018039 cites W2110057444 @default.
• W3164018039 cites W2120405223 @default.
• W3164018039 cites W2120620347 @default.
• W3164018039 cites W2127745419 @default.
• W3164018039 cites W2138250841 @default.
• W3164018039 cites W2145149205 @default.
• W3164018039 cites W2170825221 @default.
• W3164018039 cites W2207446118 @default.
• W3164018039 cites W2314753133 @default.
• W3164018039 cites W2317170392 @default.
• W3164018039 cites W2318880831 @default.
• W3164018039 cites W2342029300 @default.
• W3164018039 cites W2419439766 @default.
• W3164018039 cites W2519279652 @default.
• W3164018039 cites W2559462000 @default.
• W3164018039 cites W2567712538 @default.
• W3164018039 cites W2589701989 @default.
• W3164018039 cites W2590359520 @default.
• W3164018039 cites W2592144107 @default.
• W3164018039 cites W2625441281 @default.
• W3164018039 cites W2740572218 @default.
• W3164018039 cites W2742133220 @default.
• W3164018039 cites W2747328203 @default.
• W3164018039 cites W2747774814 @default.
• W3164018039 cites W2754151974 @default.
• W3164018039 cites W2766016099 @default.
• W3164018039 cites W2770798942 @default.
• W3164018039 cites W2943528604 @default.
• W3164018039 cites W2943781197 @default.
• W3164018039 cites W2974549300 @default.
• W3164018039 cites W2982244781 @default.
• W3164018039 cites W2993204321 @default.
• W3164018039 cites W2997884043 @default.
• W3164018039 cites W2999409012 @default.
• W3164018039 cites W3005152261 @default.
• W3164018039 cites W3012560306 @default.
• W3164018039 cites W3040408059 @default.
• W3164018039 cites W3063115110 @default.
• W3164018039 cites W3088023343 @default.
• W3164018039 cites W4234401042 @default.
• W3164018039 doi "https://doi.org/10.3389/fonc.2021.663749" @default.
• W3164018039 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8189418" @default.
• W3164018039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34123823" @default.
• W3164018039 hasPublicationYear "2021" @default.
• W3164018039 type Work @default.
• W3164018039 sameAs 3164018039 @default.
• W3164018039 citedByCount "14" @default.
• W3164018039 countsByYear W31640180392021 @default.
• W3164018039 countsByYear W31640180392022 @default.
• W3164018039 countsByYear W31640180392023 @default.
• W3164018039 crossrefType "journal-article" @default.
• W3164018039 hasAuthorship W3164018039A5009596826 @default.
• W3164018039 hasAuthorship W3164018039A5009830957 @default.
• W3164018039 hasAuthorship W3164018039A5033385764 @default.
• W3164018039 hasAuthorship W3164018039A5077640487 @default.
• W3164018039 hasBestOaLocation W31640180391 @default.
• W3164018039 hasConcept C121608353 @default.
• W3164018039 hasConcept C126322002 @default.
• W3164018039 hasConcept C143998085 @default.
• W3164018039 hasConcept C203014093 @default.
• W3164018039 hasConcept C2776694085 @default.
• W3164018039 hasConcept C2777416452 @default.
• W3164018039 hasConcept C2777701055 @default.
• W3164018039 hasConcept C2777802072 @default.
• W3164018039 hasConcept C2778220009 @default.
• W3164018039 hasConcept C2781230642 @default.
• W3164018039 hasConcept C502942594 @default.
• W3164018039 hasConcept C509974204 @default.
• W3164018039 hasConcept C535046627 @default.
• W3164018039 hasConcept C71924100 @default.
• W3164018039 hasConceptScore W3164018039C121608353 @default.
• W3164018039 hasConceptScore W3164018039C126322002 @default.
• W3164018039 hasConceptScore W3164018039C143998085 @default.
• W3164018039 hasConceptScore W3164018039C203014093 @default.
• W3164018039 hasConceptScore W3164018039C2776694085 @default.
• W3164018039 hasConceptScore W3164018039C2777416452 @default.
• W3164018039 hasConceptScore W3164018039C2777701055 @default.
• W3164018039 hasConceptScore W3164018039C2777802072 @default.

• next